L & S Advisors Inc Shockwave Medical, Inc. Transaction History

L & S Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$191.17 - $325.63 $197,096 - $335,724	-1,031 Reduced 17.52%	4,853 $1.58 Million
Q4 2023 Feb 13, 2024	BUY	$160.99 - $215.69 $947,265 - $1.27 Million	5,884 New	5,884 $1.12 Million
Q2 2023 Aug 11, 2023	BUY	$223.05 - $302.68 $757,700 - $1.03 Million	3,397 New	3,397 $969,000
Q4 2022 Feb 13, 2023	SELL	$204.38 - $296.82 $586,366 - $851,576	-2,869 Reduced 50.41%	2,822 $580,000
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $389,443 - $619,507	-1,995 Reduced 25.96%	5,691 $1.58 Million
Q2 2022 Aug 12, 2022	SELL	$115.91 - $214.48 $315,970 - $584,672	-2,726 Reduced 26.18%	7,686 $1.47 Million
Q1 2022 May 11, 2022	BUY	$127.96 - $207.36 $1.33 Million - $2.16 Million	10,412 New	10,412 $2.16 Million

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on L & S Advisors Inc with notifications on news.